IDXX vs LNTH · P/E 40, rev $2.36B vs P/E 23, rev $765.5M
IDEXX Laboratories Inc (IDXX) versus Lantheus Holdings Inc (LNTH) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Lantheus Holdings Inc (LNTH) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported LNTH revenue for 2026-06-30 was $765.5M. Net income was $193.4M. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.
Not investment advice. Open the IDXX and LNTH stock pages for the full models.
Not investment advice.